Generic placeholder image

Nanoscience & Nanotechnology-Asia

Editor-in-Chief

ISSN (Print): 2210-6812
ISSN (Online): 2210-6820

Research Article

Preparation and Evaluation of Medicated Formulation for Dry Eye

Author(s): Nishita Singh, Rahul Maurta, Sudhanshu Mishra* and Deepti Jain

Volume 13, Issue 4, 2023

Published on: 21 June, 2023

Article ID: e260523217386 Pages: 14

DOI: 10.2174/2210681213666230526152322

Price: $65

Abstract

Introduction: The current research involved the study of chondroitin sulfate polymer to prevent moisture loss, which was formulated to treat dry eye.

Methods: The ophthalmic formulation was prepared with 5% liquid paraffin wax, 10% carbowax, and 1% glycerine. Furthermore, its usefulness in ophthalmology was analyzed by measuring parameters like pH, isotonicity, turbidity, viscosity, % moisture loss, vapor pressure, and in vitro and in vivo corneal damage.

Results: We successfully adjusted the pH and osmolality of the F2 formulation to the desired physiological levels, providing the opportunity to reduce the harmful reaction as well as inflammation and dehydration. In addition, viscosity plays an important role in ophthalmic preparation. Consequently, the stability studies of optimized formulation indicated no remarkable changes in physical properties, including pH, viscosity, phase separation, and turbidity. Furthermore, a vapor pressure manometer studied the percentage of moisture loss. Interestingly, the HET-CAM test correlated properly with the findings of the Draize eye inflammation test. Moreover, the in vivo irritation test of the optimized system showed that it was tolerable, with no signs of irritation in the rabbit eye compared to the marketed formulation. In addition, the F2 formulation demonstrated better results than the marketed corneal preparation. Thereby, from the results, it can be concluded that the simple manometer apparatus can be the best method for evaluating moisture loss prevention for dry eyes. No study or investigation has been reported before for ophthalmic preparation.

Conclusion: Altogether, chondroitin sulfate with carbowax 1000 and liquid paraffin-based ophthalmic preparation can be considered a promising approach for preventing dryness of the eye.

Graphical Abstract

[1]
Viso, E.; Gude, F.; Rodríguez-Ares, M.T. The association of meibomian gland dysfunction and other common ocular diseases with dry eye: A population-based study in Spain. Cornea, 2011, 30(1), 1-6.
[http://dx.doi.org/10.1097/ICO.0b013e3181da5778] [PMID: 20847672]
[2]
Stern, ME; Beuerman, RW; Fox, RI; Gao, J; Mircheff, AK; Pflugfelder, SC The pathology of dry eye: The interaction between the ocular surface and lacrimal glands. Cornea., 1998, 17(6), 584-589.
[http://dx.doi.org/10.1097/00003226-199811000-00002]
[3]
Goto, E.; Endo, K.; Suzuki, A.; Fujikura, Y.; Matsumoto, Y.; Tsubota, K. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest. Ophthalmol. Vis. Sci., 2003, 44(2), 533-539.
[http://dx.doi.org/10.1167/iovs.02-0170] [PMID: 12556380]
[4]
Stern, M.E.; Gao, J.; Siemasko, K.F.; Beuerman, R.W.; Pflugfelder, S.C. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp. Eye Res., 2004, 78(3), 409-416.
[http://dx.doi.org/10.1016/j.exer.2003.09.003] [PMID: 15106920]
[5]
Craig, J.P.; Nichols, K.K.; Akpek, E.K.; Caffery, B.; Dua, H.S.; Joo, C.K.; Liu, Z.; Nelson, J.D.; Nichols, J.J.; Tsubota, K.; Stapleton, F. TFOS DEWS II definition and classification report. Ocul. Surf., 2017, 15(3), 276-283.
[http://dx.doi.org/10.1016/j.jtos.2017.05.008] [PMID: 28736335]
[6]
Stevenson, W.; Chauhan, S.K.; Dana, R. Dry eye disease: An immune-mediated ocular surface disorder. Arch. Ophthalmol., 2012, 130(1), 90-100.
[http://dx.doi.org/10.1001/archophthalmol.2011.364] [PMID: 22232476]
[7]
Zhu, X.; Topouzis, S.; Liang, L.; Stotish, R.L. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine, 2004, 26(6), 262-272.
[http://dx.doi.org/10.1016/j.cyto.2004.03.007] [PMID: 15183844]
[8]
Niederkorn, JY; Stern, ME; Pflugfelder, SC; De Paiva, CS; Corrales, RM; Gao, J Siemasko, K Desicating stress induces T cell-mediated Sjogren’ssyndrome-like lacrimal kerotoconjuctivitis. J. Immunol., 2006, 176(7), 3950-7.
[http://dx.doi.org/10.4049/jimmunol.176.7.3950]
[9]
Dursun, D.; Wang, M.; Monroy, D.; Li, D.Q.; Lokeshwar, B.L.; Stern, M.E.; Pflugfelder, S.C. A mouse model of keratoconjunctivitis sicca. Invest. Ophthalmol. Vis. Sci., 2002, 43(3), 632-638.
[PMID: 11867577]
[10]
Vitali, C.; Bombardieri, S.; Jonsson, R.; Moutsopoulos, H.M.; Alexander, E.L.; Carsons, S.E.; Daniels, T.E.; Fox, P.C.; Fox, R.I.; Kassan, S.S.; Pillemer, S.R.; Talal, N.; Weisman, M.H. Classification criteria for Sjogren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis., 2002, 61(6), 554-558.
[http://dx.doi.org/10.1136/ard.61.6.554] [PMID: 12006334]
[11]
Thai, L.C.; Tomlinson, A.; Doane, M.G. Effect of contact lens materials on tear physiology. Optom. Vis. Sci., 2004, 81(3), 194-204.
[http://dx.doi.org/10.1097/00006324-200403000-00012] [PMID: 15017179]
[12]
Craig, J.P.; Tomlinson, A. Importance of the lipid layer in human tear film stability and evaporation. Optom. Vis. Sci., 1997, 74(1), 8-13.
[http://dx.doi.org/10.1097/00006324-199701000-00014] [PMID: 9148269]
[13]
Hessen, M.; Akpek, E.K. Dry eye: An inflammatory ocular disease. J. Ophthalmic Vis. Res., 2014, 9(2), 240-250.
[PMID: 25279127]
[14]
Peck, T.; Olsakovsky, L.; Aggarwal, S. Dry eye syndrome in menopause and perimenopausal age group. J Midlife Health., 2017, 8(2), 51-54.
[http://dx.doi.org/10.4103/jmh.JMH_41_17]
[15]
Shen Lee, B.; Kabat, A.G.; Bacharach, J.; Karpecki, P.; Luchs, J. Managing dry eye disease and facilitating realistic patient expectations: A review and appraisal of current therapies. Clin. Ophthalmol., 2020, 14, 119-126.
[http://dx.doi.org/10.2147/OPTH.S228838] [PMID: 32021076]
[16]
Shrimali, H; Mandal, UK; Nivsarkar, M; Shrivastava, N Fabrication and evaluation of a medicated hydrogel film with embelin from Embelia ribes for wound healing activity. Future J. Pharm. Sci., 219, 5(1), 1-10.
[http://dx.doi.org/10.1186/s43094-019-0011-z]
[17]
Baudouin, C.; Aragona, P.; Messmer, E.M.; Tomlinson, A.; Calonge, M.; Boboridis, K.G.; Akova, Y.A.; Geerling, G.; Labetoulle, M.; Rolando, M. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: Proceedings of the OCEAN group meeting. Ocul. Surf., 2013, 11(4), 246-258.
[http://dx.doi.org/10.1016/j.jtos.2013.07.003] [PMID: 24112228]
[18]
Rynerson, JM; Perry, HD DEBS - a unification theory for dry eye and blepharitis. Clin. Ophthalmol., 2016, 10, 2455-2467.
[19]
Schaumberg, D.A.; Sullivan, D.A.; Dana, M.R. Epidemiology of dry eye syndrome. Adv. Exp. Med. Biol., 2002, 506(Pt B), 989-998.
[http://dx.doi.org/10.1007/978-1-4615-0717-8_140] [PMID: 12614022]
[20]
Miljanović, B.; Dana, R.; Sullivan, D.A.; Schaumberg, D.A. Impact of dry eye syndrome on vision-related quality of life. Am. J. Ophthalmol., 2007, 143(3), 409-415.e2.
[http://dx.doi.org/10.1016/j.ajo.2006.11.060] [PMID: 17317388]
[21]
Carney, L.G.; Hill, R.M. Human tear pH. Arch. Ophthalmol., 1976, 94(5), 821-824.
[http://dx.doi.org/10.1001/archopht.1976.03910030405011] [PMID: 5068]
[22]
Ahshawat, M.S.; Saraf, S.; Saraf, S. Preparation and characterization of herbal creams for improvement of skin viscoelastic properties. Int. J. Cosmet. Sci., 2008, 30(3), 183-193.
[http://dx.doi.org/10.1111/j.1468-2494.2008.00442.x] [PMID: 18452435]
[23]
Bunya, VY; Langelier, N; Chen, S; Pistilli, M; Vivino, FB Massaro-Giordano, G Tear osmolarity in Sjogren’s syndrome. Cornea, 2013, 32(7), 922-927.
[24]
Di Martino, P.; Guyot-Hermann, A-M.; Conflant, P.; Drache, M.; Guyot, J-C. A new pure paracetamol for direct compression: The orthorhombic form. Int. J. Pharm., 1996, 128(1-2), 1-8.
[http://dx.doi.org/10.1016/0378-5173(95)04127-3]
[25]
Yadav, V.K.; Gupta, A.B.; Kumar, R.; Yadav, J.S.; Kumar, B. Mucoadhesive polymers: Means of improving the mucoadhesive properties of drug delivery system. J. Chem. Pharm. Res., 2010, 2(5), 418-432.
[26]
Orafidiya, LO; Oladimeji, FA Determination of the required HLB values of some essential oils. J. Pharm. Biomed. Anal., 2002, 237(1-2), 241-9.
[http://dx.doi.org/10.1016/S0378-5173(02)00051-0]
[27]
Verma, R.K.; Garg, S. Selection of excipients for extended release formulations of glipizide through drug–excipient compatibility testing. J. Pharm. Biomed. Anal., 2005, 38(4), 633-644.
[http://dx.doi.org/10.1016/j.jpba.2005.02.026] [PMID: 15967291]
[28]
Araújo, A.; Storpirtis, S.; Mercuri, L.P.; Carvalho, F.M.; dos Santos Filho, M.; Matos, J.R. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. Int. J. Pharm., 2003, 260(2), 303-314.
[http://dx.doi.org/10.1016/S0378-5173(03)00288-6] [PMID: 12842349]
[29]
Meda, A.; Lamien, C.E.; Romito, M.; Millogo, J.; Nacoulma, O.G. Determination of the total phenolic, flavonoid and proline Contents in Burkina Fasan Honey, as well as their radical scavenging activity. Food Chem., 2005, 91(3), 571-577.
[http://dx.doi.org/10.1016/j.foodchem.2004.10.006]
[30]
Dohlman, T.H.; Chauhan, S.K.; Kodati, S.; Hua, J.; Chen, Y.; Omoto, M.; Sadrai, Z.; Dana, R. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest. Ophthalmol. Vis. Sci., 2013, 54(6), 4081-4091.
[http://dx.doi.org/10.1167/iovs.12-11216] [PMID: 23702781]
[31]
Shah, R.B.; Bryant, A.; Collier, J.; Habib, M.J.; Khan, M.A. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients. Int. J. Pharm., 2008, 360(1-2), 77-82.
[http://dx.doi.org/10.1016/j.ijpharm.2008.04.018] [PMID: 18524511]
[32]
Baranowski, P.; Karolewicz, B.; Gajda, M.; Pluta, J. Ophthalmic drug dosage forms: Characterisation and research methods. Sci. World J., 2014, 2014, 861904.
[http://dx.doi.org/10.1155/2014/861904] [PMID: 24772038]
[33]
Rolando, M.; Valente, C. Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: Results of a clinical study. BMC Ophthalmol., 2007, 7(1), 5.
[http://dx.doi.org/10.1186/1471-2415-7-5] [PMID: 17394642]
[34]
Lewicki, P.P. Measurement of water activity of saturated salt solutions with the vapourpressure manometer. J. Food Eng., 1989, 10(1), 3955.
[http://dx.doi.org/10.1016/02608774(89)90019-8]
[35]
Begley, C.G.; Waggoner, P.J.; Hafner, G.S.; Tokarski, T.; Meetz, R.; Wheeler, W.H. Effect of rigid gas permeable contact lens wetting solutions on the rabbit corneal epithelium. Optom. Vis. Sci., 1991, 68(3), 189-197.
[http://dx.doi.org/10.1097/00006324-199103000-00006] [PMID: 2047081]
[36]
Burgalassi, S.; Panichi, L.; Chetoni, P.; Saettone, M.F.; Boldrini, E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res., 1999, 31(3), 229-235.
[http://dx.doi.org/10.1159/000055537] [PMID: 10224507]
[37]
Lemp, M.A.; Foulks, G.N. The definition and classification of dry eye disease: Report of the definition and classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 2007, 5(2), 75-92.
[http://dx.doi.org/10.1016/S1542-0124(12)70081-2] [PMID: 17508116]
[38]
Matossian, C.; Trattler, W.; Loh, J. Dry eye treatment with topical cyclosporine 0.1% in chondroitin sulfate ophthalmic emulsion. Clin. Ophthalmol., 2021, 15, 1979-1984.
[http://dx.doi.org/10.2147/OPTH.S308088] [PMID: 34007151]
[39]
Moss, S.E.; Klein, R.; Klein, B.E.K. Long-term incidence of dry eye in an older population. Optom. Vis. Sci., 2008, 85(8), 668-674.
[http://dx.doi.org/10.1097/OPX.0b013e318181a947] [PMID: 18677233]
[40]
Aragona, P.; Di Stefano, G.; Ferreri, F.; Spinella, R.; Stilo, A. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren’s syndrome patients. Br. J. Ophthalmol., 2002, 86(8), 879-884.
[http://dx.doi.org/10.1136/bjo.86.8.879] [PMID: 12140209]
[41]
Moon, J.W.; Lee, H.J.; Shin, K.C.; Wee, W.R.; Lee, J.H.; Kim, M.K. Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye. Korean J. Ophthalmol., 2007, 21(4), 189-194.
[http://dx.doi.org/10.3341/kjo.2007.21.4.189] [PMID: 18063881]
[42]
Johnson, M.E.; Murphy, P.J.; Boulton, M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch. Clin. Exp. Ophthalmol., 2006, 244(1), 109-112.
[http://dx.doi.org/10.1007/s00417-005-0028-1] [PMID: 15983814]
[43]
Smolin, G.; Okumoto, M.; Feiler, S.; Condon, D. Idoxuridine-liposome therapy for herpes simplex keratitis. Am. J. Ophthalmol., 1981, 91(2), 220-225.
[http://dx.doi.org/10.1016/0002-9394(81)90177-X] [PMID: 7468738]
[44]
Jones, L.; Senchyna, M.; Glasier, M.A.; Schickler, J.; Forbes, I.; Louie, D.; May, C. Lysozyme and lipid deposition on silicone hydrogel contact lens materials. Eye Contact Lens, 2003, 29(1)(Suppl.), S75-S79.
[http://dx.doi.org/10.1097/00140068-200301001-00021] [PMID: 12772737]
[45]
Celebi, A.R.C.; Ulusoy, C.; Mirza, G.E. The efficacy of autologous serum eye drops for severe dry eye syndrome: A randomized double-blind crossover study. Graefes Arch. Clin. Exp. Ophthalmol., 2014, 252(4), 619-626.
[http://dx.doi.org/10.1007/s00417-014-2599-1] [PMID: 24566903]
[46]
De Paula, I.C.; Ortega, G.G.; Bassani, V.L.; Petrovick, P.R. Development of ointment formulations prepared with Achyrocline satureioides spray-dried extracts. Drug Dev. Ind. Pharm., 1998, 24(3), 235-41.
[http://dx.doi.org/10.3109/03639049809085615]
[47]
Nunes, RV; Urbicain, MJ; Rotstein, E Improving accuracy and precision of water activity measurements with a water vapor pressure manometer. J. Food Sci., 2006, 50(1), 148-149.
[http://dx.doi.org/10.1111/j.1365-2621.1985.tb13297.x]
[48]
Mori, K.; Qian, X.; Kuwahara, Y.; Horiuchi, Y.; Kamegawa, T.; Zhao, Y.; Louis, C.; Yamashita, H. Design of advanced functional materials using nanoporous single-site photocatalysts. Chem. Rec., 2020, 20(7), 660-671.
[http://dx.doi.org/10.1002/tcr.201900085] [PMID: 31833628]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy